in the study testing surgery versus surgery plus 12 cycles of cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) in node-positive patients , the reduction in failure rate ( 34 % ) significantly favored cmf-treated patients ( p less than 0.001 ) .
C0016360
5-fluorouracil
C0950521
cmf